The global Glucosamine market stood at approximately 117 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 4.75% during the forecast period until 2034.
Glucosamine, a naturally occurring compound in the human body, serves various health purposes, with its primary use revolving around joint health. As a key component of cartilage, Glucosamine plays a crucial role in promoting joint lubrication, cushioning, and repair, making it particularly beneficial for individuals with osteoarthritis or cartilage injuries. By stimulating the production of glycosaminoglycans (GAGs), essential cartilage constituents, Glucosamine supports joint function and mobility, helping alleviate symptoms such as pain, stiffness, and inflammation. Additionally, Glucosamine's involvement in bone health extends its utility beyond joint care, potentially preventing bone loss and improving bone mineral density, particularly in postmenopausal women at risk of osteoporosis. Furthermore, emerging research suggests that Glucosamine may have therapeutic implications for inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Beyond its internal benefits, Glucosamine is also recognized for its potential skincare benefits, with topical or oral supplementation believed to enhance skin hydration, elasticity, and collagen production, contributing to overall skin health and appearance. Overall, Glucosamine's multifaceted properties make it a valuable dietary supplement and ingredient in health and wellness products, offering comprehensive support for joint, bone, gastrointestinal, and skin health.
The Glucosamine market is experiencing significant growth driven by several key trends and drivers. As the global population continues to age, there is a corresponding increase in the prevalence of age-related joint disorders like osteoarthritis, fuelling demand for Glucosamine supplements known for their joint health benefits. Moreover, the rising awareness of preventive healthcare and the shift towards natural supplements among health-conscious consumers further boosts market growth. The expanding nutraceutical industry, coupled with the growing popularity of sports and fitness activities, drives the adoption of Glucosamine as a dietary supplement to support joint function and alleviate discomfort. Additionally, ongoing innovation and product development efforts by manufacturers, including the introduction of new formulations and combination products, cater to diverse consumer preferences and needs. The accessibility of Glucosamine supplements through various distribution channels, such as pharmacies, health food stores, and online platforms, enhances consumer access and contributes to market expansion. Overall, these trends collectively contribute to the robust growth of the Glucosamine market, indicating promising opportunities for continued expansion in the foreseeable future. The global Glucosamine market is likely to reach approximately 200 thousand tonnes in 2034.
The Asia Pacific region stands out as the primary consumer of Glucosamine, both in terms of production and consumption. Several factors contribute to this leadership position. Firstly, the region's large and diverse population, including countries such as China, Japan, India, and South Korea, presents a substantial consumer base with diverse healthcare needs. Secondly, the prevalence of conditions such as osteoarthritis and joint-related issues is relatively high in many Asian countries, owing to factors such as aging populations, changing lifestyles, and increasing urbanization. As a result, there is a growing demand for joint health supplements like Glucosamine to address these concerns. Moreover, the expanding middle class and rising disposable incomes in many Asian countries contribute to increased spending on health and wellness products, including dietary supplements. Furthermore, the presence of a robust manufacturing base for Glucosamine and related products in countries like China further strengthens the region's position as a major consumer. Overall, these factors collectively position the Asia Pacific region as the leading consumer of Glucosamine globally.
Based on the end-use industry, the global Glucosamine market is divided into Nutraceuticals, Food & Beverages, and Others. Among these industries, Nutraceuticals is the dominating segment and held about 78% of the global Glucosamine market in 2023.
Major players in the Global Glucosamine market are Koyo Chemical Industry Co., Ltd, Laboratoires Expanscience, Nutramax Laboratories Consumer Care, Inc., Amway, CELLMARK AB., Alfa Chemical Group, Cargill, Incorporated, Golden-Shell Pharmaceutical, SimplySupplements, and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Glucosamine which covers production, demand and supply of Glucosamine market in the globe.
• To analyse and forecast the market size of Glucosamine
• To classify and forecast Global Glucosamine market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Glucosamine market in the globe.
To extract data for Global Glucosamine market, primary research surveys were conducted with Glucosamine manufacturers, suppliers, distributors, wholesalers and Traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Glucosamine market over the coming years.
ChemAnalyst calculated Glucosamine demand across the globe by analyzing the volume of Glucosamine consumed by the end-user industries and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Glucosamine manufacturers and other stakeholders
• Organizations, forums and alliances related to Glucosamine distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Glucosamine manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years (next two to five years), thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Glucosamine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
117 thousand tonnes
Market size Volume in 2034
200 thousand tonnes
Growth Rate
CAGR of 4.75% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by End- Use, Demand by Region, Demand by Sales Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use: (Nutraceuticals, Food & Beverages, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Glucosamine in terms of volume in 2023?
Ans:
The global market size of Glucosamine has reached approximately 117 thousand tonnes in 2023.
Q2.
Which industry is the leading end-user industry of Glucosamine?
Ans:
Nutraceuticals industry is the leading end-user industry of Glucosamine globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database) Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.